Creekmur Asset Management LLC Gain Therapeutics, Inc. Transaction History
Creekmur Asset Management LLC
- $566 Billion
- Q2 2025
A detailed history of Creekmur Asset Management LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Creekmur Asset Management LLC holds 4,440 shares of GANX stock, worth $6,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,440
Previous 4,440
-0.0%
Holding current value
$6,571
Previous $8.48 Million
5.75%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
38Shares Held
3.67MCall Options Held
8.4KPut Options Held
8.7K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$870,8460.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$837,8720.05% of portfolio
-
Jones Financial Companies Lllp428KShares$632,9960.0% of portfolio
-
Geode Capital Management, LLC Boston, MA290KShares$429,8830.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA255KShares$377,3850.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $17.6M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...